DrugCite
Search

METOPROLOL SUCCINATE

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Metoprolol Succinate Adverse Events Reported to the FDA Over Time

How are Metoprolol Succinate adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Metoprolol Succinate, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Metoprolol Succinate is flagged as the suspect drug causing the adverse event.

Most Common Metoprolol Succinate Adverse Events Reported to the FDA

What are the most common Metoprolol Succinate adverse events reported to the FDA?

Hypertension
677 (2.06%)
Malaise
650 (1.98%)
Dizziness
640 (1.95%)
Fatigue
544 (1.65%)
Drug Dose Omission
534 (1.62%)
Blood Pressure Increased
505 (1.54%)
Drug Ineffective
505 (1.54%)
Headache
438 (1.33%)
Dyspnoea
428 (1.3%)
Myocardial Infarction
391 (1.19%)
Nausea
382 (1.16%)
Show More Show More
Hypotension
352 (1.07%)
Cerebrovascular Accident
333 (1.01%)
Palpitations
318 (.97%)
Fall
299 (.91%)
Heart Rate Increased
294 (.89%)
Asthenia
277 (.84%)
Chest Pain
266 (.81%)
Bradycardia
257 (.78%)
Insomnia
246 (.75%)
Feeling Abnormal
234 (.71%)
Diarrhoea
228 (.69%)
Cardiac Disorder
215 (.65%)
Syncope
213 (.65%)
Pain
197 (.6%)
Diabetes Mellitus
196 (.6%)
Drug Interaction
188 (.57%)
Oedema Peripheral
187 (.57%)
Weight Decreased
182 (.55%)
Anxiety
181 (.55%)
Atrial Fibrillation
181 (.55%)
Cough
176 (.54%)
Heart Rate Decreased
172 (.52%)
Pain In Extremity
166 (.5%)
Alopecia
164 (.5%)
Off Label Use
160 (.49%)
Weight Increased
158 (.48%)
Medication Error
157 (.48%)
Vomiting
153 (.47%)
Death
148 (.45%)
Gastrooesophageal Reflux Disease
147 (.45%)
Blood Pressure Inadequately Control...
146 (.44%)
Loss Of Consciousness
143 (.44%)
Somnolence
137 (.42%)
Confusional State
133 (.4%)
Depression
133 (.4%)
Muscle Spasms
129 (.39%)
Arthralgia
126 (.38%)
Abdominal Discomfort
124 (.38%)
Rash
124 (.38%)
Vision Blurred
124 (.38%)
Hypoaesthesia
123 (.37%)
Heart Rate Irregular
121 (.37%)
Back Pain
119 (.36%)
Drug Hypersensitivity
117 (.36%)
Neoplasm Malignant
117 (.36%)
Tachycardia
116 (.35%)
Completed Suicide
115 (.35%)
Pruritus
114 (.35%)
Memory Impairment
113 (.34%)
Nasopharyngitis
113 (.34%)
Blood Pressure Decreased
111 (.34%)
Myalgia
111 (.34%)
Gait Disturbance
108 (.33%)
Tremor
107 (.33%)
Bronchitis
105 (.32%)
Constipation
104 (.32%)
Dyspepsia
103 (.31%)
Incorrect Dose Administered
101 (.31%)
Intentional Drug Misuse
101 (.31%)
Chest Discomfort
99 (.3%)
Blood Glucose Increased
98 (.3%)
Wrong Technique In Drug Usage Proce...
98 (.3%)
Adverse Event
97 (.3%)
Hyperhidrosis
95 (.29%)
Blood Cholesterol Increased
93 (.28%)
Muscular Weakness
93 (.28%)
Abdominal Pain Upper
91 (.28%)
Paraesthesia
91 (.28%)
Dehydration
90 (.27%)
Drug Dispensing Error
90 (.27%)
Pneumonia
87 (.26%)
Amnesia
86 (.26%)
Dry Mouth
86 (.26%)
Peripheral Coldness
86 (.26%)
Ill-defined Disorder
85 (.26%)
Arrhythmia
83 (.25%)
Drug Intolerance
83 (.25%)
Therapeutic Response Unexpected Wit...
82 (.25%)
Blood Pressure Fluctuation
81 (.25%)
Contusion
81 (.25%)
Product Quality Issue
81 (.25%)
Anaemia
80 (.24%)
Arthritis
79 (.24%)
Cardiac Failure Congestive
78 (.24%)
Hypersensitivity
78 (.24%)
Convulsion
77 (.23%)
Product Substitution Issue
75 (.23%)
Visual Impairment
75 (.23%)
Nervousness
73 (.22%)
Road Traffic Accident
72 (.22%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Metoprolol Succinate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Metoprolol Succinate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Metoprolol Succinate

What are the most common Metoprolol Succinate adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Metoprolol Succinate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Metoprolol Succinate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Metoprolol Succinate According to Those Reporting Adverse Events

Why are people taking Metoprolol Succinate, according to those reporting adverse events to the FDA?

Hypertension
5948
Drug Use For Unknown Indication
1702
Product Used For Unknown Indication
1454
Blood Pressure
675
Cardiac Disorder
570
Atrial Fibrillation
504
Show More Show More
Coronary Artery Disease
240
Arrhythmia
171
Blood Pressure Increased
152
Tachycardia
141
Blood Pressure Abnormal
115
Heart Rate Increased
111
Palpitations
107
Heart Rate Irregular
107
Angina Pectoris
92
Myocardial Infarction
87
Cardiac Failure Congestive
75
Cardiac Failure
73
Supraventricular Tachycardia
60
Ill-defined Disorder
57
Heart Rate
53
Essential Hypertension
52
Prophylaxis
43
Heart Rate Abnormal
42
Mitral Valve Prolapse
40
Migraine
33
Cardiovascular Disorder
31
Myocardial Ischaemia
30
Ventricular Extrasystoles
26
Blood Pressure Management
22
Chest Pain
20
Cardiovascular Event Prophylaxis
20
Atrial Flutter
18
Sinus Tachycardia
17
Cardiomyopathy
17
Anxiety
17
Extrasystoles
16
Ventricular Tachycardia
14
Supraventricular Extrasystoles
14
Acute Myocardial Infarction
14
Cardiac Failure Chronic
13
Migraine Prophylaxis
12
Ischaemic Heart Disease Prophylaxis
12
Blood Cholesterol Increased
11
Hypertonia
10
Syncope
10
Coronary Artery Bypass
10
Vascular Graft
9
Acute Coronary Syndrome
8
Coronary Artery Occlusion
7
Heart Valve Incompetence
7

Drug Labels

LabelLabelerEffective
Metoprolol SuccinateBryant Ranch Prepack04-AUG-09
Metoprolol Succinate Extended-release Ethex Corporation01-NOV-09
Metoprolol Succinate Extended-release Ethex Corporation29-MAR-10
Metoprolol Succinate Extended-release Ethex Corporation29-MAR-10
Metoprolol SuccinatePD-Rx Pharmaceuticals, Inc.15-APR-10
Metoprolol SuccinatePD-Rx Pharmaceuticals, Inc.15-APR-10
Metoprolol SuccinateMcKesson Packaging Services Business Unit of McKesson Corporation02-FEB-11
DutoprolAstraZeneca LP08-FEB-11
Metoprolol SuccinateRebel Distributors Corp03-JUN-11
Metoprolol SuccinateRebel Distributors Corp01-SEP-11
Metoprolol SuccinateMylan Pharmaceuticals Inc.08-DEC-11
DutoprolAstraZeneca Pharmaceuticals LP19-DEC-11
Metoprolol SuccinateGolden State Medical Supply, Inc.09-JAN-12
Metoprolol SuccinateAmerican Health Packaging24-JAN-12
ToprolxlPhysicians Total Care, Inc.03-FEB-12
Metoprolol Succinate Bryant Ranch Prepack19-MAR-12
Metoprolol SuccinateMylan Institutional Inc.04-MAY-12
Metoprolol SuccinateNCS HealthCare of KY, Inc dba Vangard Labs08-JUN-12
Metoprolol SuccinatePhysicians Total Care, Inc.20-JUN-12
Metoprolol SuccinateMajor Pharmaceuticals17-JUL-12
ToprolxlCardinal Health01-AUG-12
Metoprolol SuccinateWatson Pharma, Inc.01-AUG-12
ToprolxlLake Erie Medical DBA Quality Care Products LLC23-AUG-12
Metoprolol SuccinateInternational Labs, Inc.13-SEP-12
Metoprolol SuccinateDispensing Solutions, Inc.27-SEP-12
Metoprolol Succinate Bryant Ranch Prepack12-OCT-12
Metoprolol SuccinatePar Pharmaceutical Inc.31-OCT-12
ToprolxlAstraZeneca LP31-OCT-12
Metoprolol SuccinateDr. Reddy's Laboratories Limited13-DEC-12
Metoprolol SuccinateDr. Reddy's Laboratories Limited13-DEC-12
ToprolxlBryant Ranch Prepack17-JAN-13
ToprolxlBryant Ranch Prepack17-JAN-13
ToprolxlBryant Ranch Prepack17-JAN-13
ToprolxlBryant Ranch Prepack18-JAN-13
Metoprolol SuccinateWOCKHARDT USA LLC12-FEB-13
Metoprolol SuccinateWOCKHARDT LIMITED12-FEB-13
Metoprolol SuccinateREMEDYREPACK INC. 08-MAR-13
Metoprolol SuccinateCardinal Health08-MAR-13
Metoprolol SuccinateREMEDYREPACK INC. 08-MAR-13
ToprolxlxlREMEDYREPACK INC. 08-MAR-13
Metoprolol SuccinateREMEDYREPACK INC. 08-MAR-13

Metoprolol Succinate Case Reports

What Metoprolol Succinate safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Metoprolol Succinate. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Metoprolol Succinate.